Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients

A. Acquaviva | U. Dianzani | C. Gramaglia | P. Zeppegno | A. Maconi | G. Gaidano | M. Invernizzi | A. Baricich | C. Cisari | P. Marzullo | D. Ferrante | R. Cantello | F. Faggiano | V. Cantaluppi | F. Della Corte | M. Pirisi | A. Rognoni | G. Patti | M. Mennuni | M. Sciarra | C. Rigamonti | M. Panella | D. Azzolina | R. Vaschetto | C. Olivieri | P. Savoia | A. Carriero | G. Aimaretti | C. Comi | L. Scotti | L. Castello | G. Avanzi | P. Sainaghi | M. Krengli | Z. Falaschi | Alessio Pasché | Leonardo Grisafi | E. Spinoni | A. Gennari | M. Malerba | F. Gavelli | P. Balbo | P. Boffano | M. Brucoli | A. Parisini | L. Lorenzini | P. Garavelli | M. Garzaro | M. Bellan | M. Santagostino | M. Betti | T. Daffara | A. Ferrero | F. Barone-Adesi | S. Borrè | A. Nuzzo | L. C. Gironi | C. Smirne | E. Zavattaro | L. Boglione | G. Chichino | Roberta Re | V. Vassia | I. Percivale | Pietro S C Danna | M. Barini | I. Leone | V. Lio | Ileana Gagliardi | E. Calzaducca | G. F. Manfredi | M. Bertolotti | E. Cammarata | D. Zagaria | Pietro S. C. Danna | Roberto Arioli | A. Pedrinelli | V. Tarantino | E. Hayden | P. Aluffi Valletti | Roberto Angilletta | G. Avino | Giulia Baldon | Francesca Baorda | E. Barbero | Sofia Battistini | Michela Beltrame | M. Bertoli | Stephanie Bertolin | F. Bobbio | A. Capponi | F. G. Casciaro | F. Ceruti | E. Chirico | M. Cittone | C. Colombo | E. Croce | S. De Vecchi | D. Di Benedetto | Elia Esposto | A. Galbiati | Silvia Gallo | C. A. Gardino | M. L. Gastaldello | Greta Maria Giacomini | Irene Giacone | Valentina Giai Via | Francesca Giolitti | Ilaria Inserra | E. Labella | I. Landi | R. Landi | M. Martelli | Letizia Marzari | Claudia Montabone | Umberto Morosini | Marco Mussa | Ilaria Nerici | Samuel Alberto Padelli | A. Pau | E. Rizzi | A. Roveta | Luigia Salamina | Massimo Saraceno | A. Schimmenti | Paolo Amedeo Tillio | Francesca Zottarelli | S. Padelli | M. Mussa | L. Grisafi | G. Manfredi | G. M. Giacomini | Paolo Aluffi Valletti

[1]  K. Farsalinos,et al.  Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply , 2020, Internal and Emergency Medicine.

[2]  C. Mantzoros,et al.  Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York , 2020, Metabolism.

[3]  C. Mantzoros,et al.  Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York , 2020, Metabolism.

[4]  M. Trauner,et al.  Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series , 2020, Annals of Internal Medicine.

[5]  S. Glantz,et al.  Smoking Is Associated With COVID-19 Progression: A Meta-analysis , 2020, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[6]  K. Farsalinos,et al.  Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? , 2020, Internal and Emergency Medicine.

[7]  Huan Li,et al.  Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Hospitalized Patients in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[9]  S. Glantz,et al.  Smoking is Associated with COVID-19 Progression: A Meta-Analysis , 2020, medRxiv.

[10]  W. Liang,et al.  Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China , 2020, Chest.

[11]  G. Lippi,et al.  Clinical and demographic characteristics of patients dying from COVID‐19 in Italy vs China , 2020, Journal of medical virology.

[12]  S. Merler,et al.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.

[13]  D. McGonagle,et al.  The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease , 2020, Autoimmunity Reviews.

[14]  C. Eastin,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The Journal of Emergency Medicine.

[15]  L. Cavanna,et al.  Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy) , 2020, Future oncology.

[16]  W. Dietz,et al.  Obesity and its Implications for COVID‐19 Mortality , 2020, Obesity.

[17]  Dengju Li,et al.  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy , 2020, Journal of Thrombosis and Haemostasis.

[18]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[19]  Baoping Yu,et al.  Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study , 2020, BMC Infectious Diseases.

[20]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[21]  Yungang He,et al.  Age-Dependent Risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China , 2020, Frontiers in Medicine.

[22]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[23]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[24]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .

[25]  Chao Lu,et al.  Retrospective study , 2016, Medicine.

[26]  P. Marik,et al.  A Descriptive Study , 2015 .

[27]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[28]  E. Steyerberg,et al.  [Regression modeling strategies]. , 2011, Revista espanola de cardiologia.

[29]  F. Schmidt.  Meta-Analysis , 2008 .

[30]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[31]  Rodney X. Sturdivant,et al.  Applied Logistic Regression: Hosmer/Applied Logistic Regression , 2005 .

[32]  F. Harrell,et al.  Evaluating the yield of medical tests. , 1982, JAMA.

[33]  C. A. Fleming,et al.  The Acquisition of Data , 1969 .

[34]  C. Dolea,et al.  World Health Organization , 1949, International Organization.